The Proactive Myeloma Patient: Putting Key Myeloma Research & Treatments News Into Perspective

September 23, 2018

An audience of myeloma patients and their caregivers joined us at a recent town meeting along with Winship Cancer Institute of Emory University to hear the latest treatment and research news, inspiring stories of people living well with myeloma, tips for effective communication and more.

We are also planning events in others cities. If you haven't already, please sign up for email updates so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled.

Patient Folder

Progress in CAR-T Cell Therapy for Myeloma: What Does the Future Hold?

Watch now to hear myeloma expert Dr. Rafael Fonseca explain where research is today for CAR-T cell therapy, clinical trial studies for the innovative immunotherapy, and more.


Is There a Racial or Ethnic Disparity in Myeloma Data?

At a recent town meeting in Atlanta, renowned myeloma expert Dr. Ajay Nooka discusses clinical trial research on the biological implications of more frequently diagnosed patient populations. Watch now to learn more.


Precision Medicine for Myeloma: Are There New Targeted Drugs in Development?

Where is research today on precision medicine for multiple myeloma? Watch now to hear renowned myeloma expert Dr. Jonathan Kaufman give an important update on targeted therapies.


How Do I Best Evaluate Myeloma Treatment Options After Relapse?

What course of action should myeloma patients take after a relapse? Does the nature of relapse vary from patient to patient? Watch now to hear experts Dr. Jonathan Kaufman and Dr. Rafael Fonseca explain.


Developments in Myeloma: What Are BiTEs?

How can BiTES benefit myeloma patients? Noted myeloma expert Dr. Jonathan Kaufman explains how the immunotherapy works to treat multiple myeloma and where research is today. Watch now to find out more.


How Do I Know When to Switch Myeloma Treatments?

How does disease risk-level influence a patient’s treatment journey? What signs indicate a need to switch therapies? Watch now to find out from myeloma expert Dr. Ajay Nooka.


What Factors Determine If I Have High-Risk Myeloma?

How does risk level change the course of treatment for myeloma patients? Tune in to hear noted myeloma expert Dr. Rafael Fonseca discuss risk stratification and explain how high-risk patients are identified and treated.


What Is the Role of Minimal Residual Disease (MRD) Testing in Myeloma Care?

What is the role of MRD testing in myeloma care? Tune in to hear renowned myeloma expert Dr. Rafael Fonseca explain what MRD testing can detect about a patient’s response to therapy, remaining myeloma cells and what it means for the course of treatment.


How Is Remission Defined for Myeloma Patients With Refractory Status?

What determines a good response to therapy? What can patients in refractory status expect from treatment? Watch now to hear Dr. Jonathan Kaufman give an expert perspective on response, remission, minimal residual disease (MRD) and refractory status.


Showing 9 of 11 programs
Host & Guests

Host and Patient Advocate, living with myeloma since 1995; Board member, Patient Empowerment Network


Associate Professor and Associate Vice-Chair for Quality and Safety, Department of Hematology and Medical Oncology, Emory University School of Medicine; Medical Director and Section Chief, Ambulatory Infusion Centers

Winship Cancer Institute


Winship Cancer Institute

Nurse Practitioner

Winship Cancer Institute

Site Director, Hematological Malignancies

Mayo Clinic Arizona

Patient Advocate

Myeloma Patient

This town meeting is sponsored by Amgen, Janssen Pharmaceuticals and Adaptive Biotechnologies. It is produced by Patient Power in partnership with Winship Cancer Institute of Emory University.

Patient Power
Winship Cancer Institute
Join Our Community Register for Events Read Our Latest Blog

Page last updated on January 17, 2019